Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis
Microbiology Spectrum · 05.11.2024 · 12 (11)
DOI: 10.1128/spectrum.00962-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 05.11.2024. Verfasst von Yuan Fang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, Chi…. Hauptthemen laut MEDLINE: Metabolome, Microbiota, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National High Level Hospital Clinical Research Funding, CAMS | Chinese Academy of Medical Sciences Initiative for Innovative Medicine (), National Multidisciplinary Cooperative Diagnosis and Treatment Capacity Building Project for Diseases.
Abstract (Originalsprache)
Pancreatic cancer, predominantly pancreatic ductal adenocarcinoma (PDAC), is one of the most malignant tumors of the digestive system. Emerging evidence suggests the involvement of the microbiome and metabolic substances in the development of PDAC, yet the results remain contradictory. This study aims to identify the alterations and relationships in intratumoral microbiome and metabolites in PDAC. We collected matched tumor and normal adjacent tissue (NAT) samples from 105 PDAC patients and performed a 6-year follow-up. 2bRAD-M sequencing, untargeted liquid chromatography-tandem mass spectrometry, and untargeted gas chromatography-mass spectrometry were performed. Compared with NATs, microbial α-diversity decreased in PDAC tumors. The relative abundance of Staphylococcus aureus , Cutibacterium acnes, and Cutibacterium granulosum was higher in PDAC tumor after adjusting for confounding factors body mass index and M stage, and the presence of Ralstonia pickettii_B was found associated with a worse overall survival. Metabolomic analysis revealed distinctive differences in composition between PDAC and NAT, with 553 discriminative metabolites identified. Differential metabolites were revealed to originate from the microbiota and showed significant interactions with shifted bacterial species through KO (KEGG Orthology) genes. These findings suggest that the PDAC microenvironment harbors unique microbial-derived enzymatic reactions, potentially influencing the occurrence and development of PDAC by modulating the levels of glycerol-3-phosphate, succinate, carbonate, and beta-alanine. IMPORTANCE We conducted a large sample-size pancreatic adenocarcinoma microbiome study using a novel microbiome sequencing method and two metabolomic assays. Two significant outcomes of our analysis are: (i) commensal opportunistic pathogens Staphylococcus aureus , Cutibacterium acnes , and Cutibacterium granulosum were enriched in pancreatic ductal adenocarcinoma (PDAC) tumors compared with normal adjacent tissues, and (ii) worse overall survival was found related to the presence of Ralstonia pickettii_B . Microbial species affect the tumorigenesis, metastasis, and prognosis of PDAC via unique microbe-enzyme-metabolite interaction. Thus, our study highlights the need for further investigation of the potential associations between pancreatic microbiota-derived omics signatures, which may drive the clinical transformation of microbiome-derived strategies toward therapy-targeted bacteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
- Key Laboratory of Research in Pancreatic Tumor, Chinese Academy of Medical Sciences, Beijing, China.
- National Science and Technology Key Infrastructure on Translational Medicine in Peking Union Medical College Hospital, Beijing, China.
- State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China.
ORCID-Profile: Shi Huang, Lei You, Yupei Zhao
Förderung
- National High Level Hospital Clinical Research Funding
- CAMS | Chinese Academy of Medical Sciences Initiative for Innovative Medicine ()
- National Multidisciplinary Cooperative Diagnosis and Treatment Capacity Building Project for Diseases
- Nonprofit Central Research Institute Fund of CAMS
- MOST | National Natural Science Foundation of China (NSFC)
- National Multidisciplinary Cooperative Diagnosis and Treatment Capacity Building Project for Major Diseases
Zitieren
APA
Fang, Y., Liu, X., Ren, J., Wang, X., Zhou, F., Huang, S., You, L., & Zhao, Y. (2024). Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis. Microbiology Spectrum, 12(11). https://doi.org/10.1128/spectrum.00962-24
Vancouver
Fang Y, Liu X, Ren J, Wang X, Zhou F, Huang S, et al. Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis. Microbiology Spectrum. 2024;12(11). doi:10.1128/spectrum.00962-24
BibTeX
@article{Fang2024,
author = {Fang, Yuan and Liu, Xiaohong and Ren, Jie and Wang, Xing and Zhou, Feihan and Huang, Shi and You, Lei and Zhao, Yupei},
title = {Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis},
journal = {Microbiology Spectrum},
year = {2024},
volume = {12},
number = {11},
doi = {10.1128/spectrum.00962-24}
}
EUVIMED